Officially: Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.
The resolution asks the FDA to review abortion pill safety again. It also asks the agency to share a full public report on real-world problems and outcomes. It does not change access rules by itself.
Where it stands
Sitting in House Committee
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
Latest: Referred to the House Committee on Energy and Commerce. (10/10/2025)
House Floor Vote
Voted on by House
Agreed to in House
Adopted by House
For more detail
